Journal
BRAIN RESEARCH
Volume 912, Issue 2, Pages 176-180Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0006-8993(01)02734-2
Keywords
guanosine; glutamate uptakes; seizures; excitotoxicity; epilepsy; adenosine
Categories
Ask authors/readers for more resources
Intraperitoneal guanosine has been shown to prevent quinolinic acid-induced seizures in mice. in this study, we investigated the effect of orally administered guanosine on seizures induced by the glutamate agonists quinolinic acid and kainate, and the endogenous glutamate releaser alpha -dendrotoxin. Guanosine (7.5 mg/kg, per os), administered 75 min in advance, prevented 70% of seizures induced by i.c.v. quinolinic acid, being as efficient as the NMDA channel blocker MK-801 administered intraperitoneally. Guanosine was ineffective against kainate-induced seizures, but significantly reversed the potentiation of seizures and death caused by the concomitant injection of MK-801. Guanosine also significantly prevented seizures and death induced by i.c.v. alpha -dendrotoxin, whereas MK-801 and phenobarbital only prevented death. Altogether, our findings underscore the therapeutic potential of oral administration of guanosine for treating diseases involving glutamatergic excitotoxicity, including epilepsy. (C) 2001 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available